Observational Study
Copyright ©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Jul 14, 2014; 20(26): 8674-8680
Published online Jul 14, 2014. doi: 10.3748/wjg.v20.i26.8674
Combination of symptoms, syndrome and disease: Treatment of refractory diabetic gastroparesis
Jun-Ling Li, Min Li, Bing Pang, Qiang Zhou, Jia-Xing Tian, Hong-Xing Liu, Xi-Yan Zhao, Xiao-Lin Tong
Jun-Ling Li, Bing Pang, Qiang Zhou, Xi-Yan Zhao, Xiao-Lin Tong, Department of Endocrinology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China
Jun-Ling Li, Jia-Xing Tian, Hong-Xing Liu, Beijing University of Traditional Chinese Medicine, Beijing 100029, China
Min Li, Molecular Biology Laboratory, Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China
Author contributions: Tong XL, Li JL, Li M and Zhou Q designed the research; Li JL, Pang B, Tian JX, Liu HX, Zhao XY performed the research; Li JL and Pang B analyzed the data and wrote the paper.
Supported by The National Key Basic Research And Development Plan, No. 2010CB530601; National Natural Science Foundation of China, No. 81173259
Correspondence to: Xiao-Lin Tong, Professor of Medicine, Department of Endocrinology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences, 5 Beixiange Street, Xuanwu District, Beijing 100053, China. xiaolintong66@sina.com
Telephone: +86-10-88001260 Fax: +86-10-63014195
Received: December 17, 2013
Revised: February 24, 2014
Accepted: April 15, 2014
Published online: July 14, 2014
Abstract

AIM: To assess effect of combination of symptoms, syndrome and disease on treatment of diabetic gastroparesis with severe nausea and vomiting.

METHODS: Professor Tong Xiaolin’s clinical electronic medical records of patients who were treated between January 1, 2006 and October 1, 2012 were used as a database. Patients who met the inclusion criteria were enrolled. General information (name, sex and age), symptoms and blood glucose levels were obtained from the clinic electronic medical record, which was supplemented by a telephone interview. The patient-rated Gastroparesis Cardinal Symptom Index (GCSI) was used to evaluate the severity of the symptoms of gastroparesis. The effects of the treatment were assessed by the change in the severity of the symptoms of gastroparesis and the change in blood glucose between the baseline levels and the post-treatment levels at 1, 2, 4, 8 and 12 wk.

RESULTS: Forty-five patients had a mean GCSI nausea and vomiting severity score of 4.21 ± 0.67 and a total GCSI score of 2.77 ± 0.63 before treatment. There was a significant improvement in the nausea and vomiting score at every return visit compared with the baseline score (1 wk: 3.02 ± 1.04 vs 4.18 ± 0.71, P < 0.001; 2 wk: 2.32 ± 1.25 vs 4.16 ± 0.73, P < 0.001; 4 wk: 2.12 ± 1.26 vs 4.12 ± 0.73, P < 0.001; 8 wk: 1.79 ± 1.09 vs 4.24 ± 0.77, P < 0.001; 12 wk: 0.69 ± 0.92 vs 4.25 ± 0.70, P < 0.001). Twenty-five of the 45 patients had complete resolution of vomiting during the observation period (mean time to resolution was 37.9 ± 27.3 d). The postprandial fullness and early satiety subscale, bloating subscale and total GCSI scores were also improved. Finally, the blood glucose levels improved after treatment, although the change was not significant.

CONCLUSION: Use of the combination of symptoms, syndrome and disease to treat diabetic gastroparesis with refractory nausea and vomiting may be a new treatment option.

Keywords: Diabetic gastroparesis, Refractory nausea and vomiting, Traditional Chinese medicine, Treatment, Gastroparesis Cardinal Symptom Index

Core tip: Limited therapeutic options exist for the treatment of diabetic gastroparesis (DGP) with refractory nausea and vomiting. Traditional Chinese medicine (TCM) has supplied important complementary and alternative treatments. Professor Tong Xiaolin is an expert in the use of TCM for severe gastroparesis in China. The combination of symptoms, syndrome and disease is a concept that he incorporates into his clinical practice. This article introduces how he uses this concept to treat DGP and assesses its effect by analysis of his clinical electronic medical records. It may provide a new treatment option for refractory disease associated with DGP.